Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02661828 · ClinicalTrials.gov registry record · NA
Tapering Off Antidepressants
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02661828 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 2 participants.
The verdict
NCT02661828, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two ways to stop taking an antidepressant medication and determine whether a faster or slower taper is better tolerated.
Interventions
- OTHER Two-Week Antidepressant Taper Regimen
- OTHER One-Week Antidepressant Taper Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02661828
The ClinicalTrials.gov registry entry for NCT02661828 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Two-Week Antidepressant Taper Regimen is the first listed.
NCT02661828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02661828 about?
NCT02661828 is a clinical study titled "Tapering Off Antidepressants". The purpose of this study is to compare two ways to stop taking an antidepressant medication and determine whether a faster or slower taper is better tolerated.
What is the current status of trial NCT02661828?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-01. Estimated completion is 2017-03-17.
What interventions are being tested in trial NCT02661828?
The interventions under investigation include: Two-Week Antidepressant Taper Regimen (OTHER), One-Week Antidepressant Taper Regimen (OTHER).
Who is sponsoring clinical trial NCT02661828?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.